『Intra-Aortic Balloon Pumps: Timing, Traces and Trials』のカバーアート

Intra-Aortic Balloon Pumps: Timing, Traces and Trials

Intra-Aortic Balloon Pumps: Timing, Traces and Trials

無料で聴く

ポッドキャストの詳細を見る
Two in the morning, day one after a long CABG. The patient has a balloon pump in, the augmented pressure has dropped, and the urine output has fallen away over the last three hours. The easiest thing in the world at that hour is to re-zero the transducer, decide the trace looks a bit better, and go back to what you were doing. By the end of this episode you'll know exactly why that's the wrong answer. This is the intra-aortic balloon pump, top to bottom, pitched at Final FRCA and a bit past it — it has appeared in past papers three separate ways, as principles, as indications and contraindications, and as complications. But the version worth having is the one where you can look at a trace on the unit and know what's wrong with it. Please note: the weaning approach and anticoagulation discussed are Wythenshawe-specific local practice. Take the principles, and check your own guidelines. We start with helium, and the two reasons to give rather than one — it's low density, so it shuttles down a long narrow catheter fast enough to work inside a fraction of a cardiac cycle, and it's highly soluble in blood, so rupture is far more forgiving than air would be. Then counterpulsation, and the sentence the whole device hangs on: the balloon pump increases myocardial oxygen supply and reduces demand at the same time, which almost nothing else does. Give adrenaline to an ischaemic ventricle and coronary perfusion may improve, but rate, contractility and wall stress have all gone up, so you've bought a little flow at a large metabolic price. Diastolic augmentation raises coronary perfusion pressure, presystolic deflation drops aortic end-diastolic pressure and therefore afterload and wall stress — supply up, demand down. Then the trace, as a learnable set piece. The rule first: put the pump on 1:2, so every other beat is unassisted and you have a control sitting next to your test. Then three comparisons in order — augmented diastolic higher than unassisted systolic, assisted end-diastolic lower than unassisted end-diastolic, and assisted systolic lower than unassisted systolic. That last one catches people every time: a lower assisted systolic pressure is not the pump failing, it's direct evidence you have unloaded the ventricle. The four timing errors get sorted by harm rather than by name, which is the distinction that shows understanding rather than recall. Early inflation and late deflation both load the ventricle during ejection and are the dangerous pair — late deflation worst of all, because the ventricle is ejecting against an inflated balloon. Late inflation and early deflation merely waste benefit, although early deflation can drive retrograde coronary and carotid flow and cause angina. Then triggers, the asynchronous mode and why you'd ever want it, and why arrhythmia is the balloon pump's great enemy. Indications and contraindications follow, including the most satisfying piece of physiology in the episode: why a balloon pump helps in acute severe mitral regurgitation. The ventricle has two exits, and how much blood goes each way depends on the relative resistance of the two routes — so dropping aortic end-diastolic pressure makes the forward path easier, the regurgitant fraction falls, and forward output rises. You're not fixing the valve, you're changing the arithmetic while somebody organises theatre. And on the other side, why aortic regurgitation is an absolute hard stop: everything the balloon does in diastole raises aortic root pressure, so in an incompetent valve you are augmenting the leak straight back into a failing ventricle. Then placement and the landmarks that matter, what TOE adds, the daily chest film, complications split into insertion, use and removal, and back to the 2am patient — falling urine output means think down, a lost left radial pulse means think up, and helium or blood in the tubing means rupture and it comes out now. We finish on the trap. IABP-SHOCK II was negative, and Altshock-2 in 2025 was stopped for futility in heart failure–related shock. So why is there one running in bed four? The answer isn't to ignore the evidence — it's to notice what those trials actually studied, which was routine, unselected use in two specific shock populations. That is a different question from the patient who cannot come off bypass, the one with acute severe mitral regurgitation waiting for theatre, or the one who needs to survive four hours until the cath lab. Chapters (00:00) Cold open — the augmented pressure has dropped(01:00) Why this episode, and what level we're pitching at(01:40) What it actually is, and why helium — two reasons(02:45) Counterpulsation: supply up and demand down at once(03:45) Inflation, and why the left ventricle is perfused in diastole(04:15) Deflation, afterload and wall stress(05:15) The trace — and why you put it on 1:2(06:05) Reading a pair of beats(07:35) Lower is better: the comparison everyone misreads(08:05) The four timing errors,...
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません